Phase II Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1–Pretreated Metastatic Non–Small Cell Lung Cancer and Metastatic Cutaneous MelanomaSylvia M. Lee, Charles Lance Cowey|Clinical Cancer Research|2024Cited by 7